Tag: mRNA-1273

Indian government approves use of Moderna’s Covid-19 Vaccine Moderna

businessnewstoday- June 29, 2021 0

US biotech company Moderna has been given emergency use authorization from the Indian government for its Covid-19 Vaccine Moderna (mRNA-1273) in adults aged 18 years ... Read More

Samsung Biologics to manufacture Moderna’s mRNA-1273 COVID-19 vaccine

businessnewstoday- May 24, 2021 0

Moderna has signed a manufacturing services and supply agreement with Samsung Biologics under which the latter will undertake large scale, commercial fill-finish manufacturing for the ... Read More

US FDA authorizes Moderna Covid-19 vaccine mRNA-1273

pharmanewsdaily- December 19, 2020 0

Moderna Covid-19 vaccine : The US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for mRNA-1273, the messenger RNA (mRNA) Covid-19 vaccine ... Read More

COVID-19 vaccine trials : Research Centers of America begins enrollment of healthy volunteers

pharmanewsdaily- August 4, 2020 0

Research Centers of America (RCA), an independent research site in  Broward County, Florida, said that it is currently holding COVID-19 vaccine trials, implemented under the ... Read More

Moderna, Rovi to collaborate on fill-finish manufacturing of mRNA-1273

pharmanewsdaily- July 12, 2020 0

Moderna and Laboratorios Farmacéuticos Rovi have entered into a collaboration for large-scale, commercial fill-finish manufacturing of mRNA-1273, the former's mRNA vaccine candidate against COVID-19, at ... Read More

Moderna completes enrollment for phase 2 trial of mRNA-1273

pharmanewsdaily- July 9, 2020 0

Moderna said that it has concluded enrollment for the two cohorts of the phase 2 study of its COVID-19 vaccine candidate mRNA-1273. According to the ... Read More

Coronavirus vaccine trial results : Moderna mRNA-1273 shows early promise

pharmanewsdaily- May 19, 2020 0

Moderna said that mRNA-1273, its novel coronavirus vaccine candidate, has delivered positive interim data in a phase 1 clinical trial by eliciting neutralizing antibody titer ... Read More

Coronavirus vaccine trial : Moderna doses first subject with mRNA-1273 in phase 1 trial

pharmanewsdaily- March 17, 2020 0

Coronavirus vaccine trial : US biotech company Moderna has dosed the first participant in the phase 1 study of mRNA-1273, its mRNA vaccine against the ... Read More